Free Trial

NeuroPace (NPCE) SEC Filings & 10K Form

NeuroPace logo
$8.98 -0.70 (-7.23%)
(As of 11/15/2024 ET)

Recent NeuroPace SEC Filings

DateFilerForm TypeView
11/14/2024
5:30 PM
NeuroPace (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
11/04/2024
3:51 PM
Kent Lake PR LLC (Filed by)
NeuroPace (Subject)
Form SCHEDULE 13G
10/28/2024
6:02 AM
KCK LTD. (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/24/2024
1:23 PM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
9:35 AM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
9:17 AM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:15 PM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:05 PM
KCK LTD. (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:14 PM
NeuroPace (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/10/2024
4:30 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
4:17 PM
NeuroPace (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
3:16 PM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
5:38 PM
NeuroPace (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
4:10 PM
NeuroPace (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
4:25 PM
NeuroPace (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
4:07 PM
NeuroPace (Subject)
Ridley Irina (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
4:48 PM
NeuroPace (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
7:54 PM
Kuhn Rebecca (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:56 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:52 PM
Becker Joel (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
6:00 PM
NeuroPace (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
02/09/2024
12:25 PM
MORGAN STANLEY (Filed by)
NeuroPace (Subject)
Form SC 13G/A
02/09/2024
8:28 AM
FMR LLC (Filed by)
NeuroPace (Subject)
Form SC 13G/A
02/06/2024
6:16 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
8:20 AM
NeuroPace (Subject)
Soleus Private Equity Fund I, L.P. (Filed by)
Form SC 13G/A
02/01/2024
8:47 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2024
5:04 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:05 AM
NeuroPace (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2023
4:47 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
3:21 PM
Morrell Martha (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
4:18 PM
Morrell Martha (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
4:59 PM
Morrell Martha (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
8:57 PM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
4:35 PM
KCK LTD. (Reporting)
NeuroPace (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2023
12:37 PM
KCK LTD. (Reporting)
NeuroPace (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NPCE) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners